You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 18, 2024

Litigation Details for AstraZeneca AB v. Zydus Pharmaceuticals (USA) Inc. (D. Del. 2018)


✉ Email this page to a colleague

« Back to Dashboard


AstraZeneca AB v. Zydus Pharmaceuticals (USA) Inc. (D. Del. 2018)

Docket ⤷  Try a Trial Date Filed 2018-05-01
Court District Court, D. Delaware Date Terminated 2022-07-28
Cause 35:271 Patent Infringement Assigned To Richard Gibson Andrews
Jury Demand None Referred To
Parties ZYDUS PHARMACEUTICALS (USA) INC.
Patents 10,232,003; 10,406,172; 6,414,126; 6,515,117; 7,851,502; 7,919,598; 7,943,582; 7,943,788; 8,221,786; 8,222,219; 8,361,972; 8,501,698; 8,513,202; 8,551,957; 8,685,934; 8,716,251; 8,785,403
Attorneys Alan B. Clement
Firms Phillips, McLaughlin & Hall, P.A.
Link to Docket External link to docket
Small Molecule Drugs cited in AstraZeneca AB v. Zydus Pharmaceuticals (USA) Inc.
Biologic Drugs cited in AstraZeneca AB v. Zydus Pharmaceuticals (USA) Inc.
The biologic drug covered by the patents cited in this case is ⤷  Try a Trial .

Details for AstraZeneca AB v. Zydus Pharmaceuticals (USA) Inc. (D. Del. 2018)

Date Filed Document No. Description Snippet Link To Document
2020-10-19 102 Notice of Service Invalidity of the Asserted Claims of U.S. Patent No. 6,515,117; (2) the Reply Expert Report of Garry Tobin…Invalidity of the Asserted Claims of U.S. Patent No. 6,515,117; and (3) the Expert Report of Radojka Savic…2018 28 July 2022 1:18-cv-00664 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
2018-06-22 11 Patent/Trademark Report to Commissioner of Patents the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,851,502 ;7,919,598 ;8,221,786…2018 28 July 2022 1:18-cv-00664 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
2021-01-25 128 Redacted Document ANDA Products”) infringes U.S. Patent No. 6,515,117 (“the ’117 patent”); WHEREAS, Zydus has …has asserted that the claims of the ‘117 patent are invalid and, therefore, not infringed; WHEREAS…2018 28 July 2022 1:18-cv-00664 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
2021-05-11 139 Redacted Document 232:2 H, L, R 231:2 232:4-10 232:3 232:17-25 233:2-3 … U.S. Patent No. 6,774,112 (“the ’112 patent”) on August 10, 2004. 90. U.S. Patent Application… preclude patentability”). 17. When a patent challenger contends that a patent is obvious…Its NDA, and the ’117 Patent 1. This is a civil action for patent infringement, arising …AstraZeneca’s Orange Book-listed U.S. Patent No. 6,515,117 (“the ’117 patent”). One indication of FARXIGA® External link to document
2021-06-14 145 Exhibit List May 17 | “Vier | semen, | United States Patent No. 6,515,117 0004 May 17 |", | “"""…quot;"| Certified File History for U.S. Patent 6,515,117 0027 May 17 Gribble | Gribble |Confidential…0090 May 17 | Gribble | Gribble | United States Patent No. 7,863,327 - Gribble et al. 0091 May 17 IGribble…USA) Inc.'s Invalidity Contentions for U.S. Patent Nos. 7,943,788; 8,785,403 & 8,785,403 01 54…iemaay’ | Certified File History for United States Patent Application No. 16/014,479 0263 May 18 | Batchelor External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.